Polianta Ltd Invests $1.57 Million in Cigna Group $CI

Polianta Ltd bought a new stake in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,700 shares of the health services provider’s stock, valued at approximately $1,568,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Dodge & Cox increased its stake in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after acquiring an additional 354,615 shares during the last quarter. Sanders Capital LLC lifted its stake in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after purchasing an additional 35,150 shares during the last quarter. Capital Research Global Investors lifted its stake in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Cigna Group by 7.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock worth $777,012,000 after purchasing an additional 186,880 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after purchasing an additional 753,865 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

CI opened at $257.97 on Tuesday. The business has a fifty day moving average of $276.81 and a 200 day moving average of $279.82. The stock has a market cap of $67.98 billion, a P/E ratio of 11.63, a PEG ratio of 0.91 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Analysts Set New Price Targets

Several research firms recently weighed in on CI. Truist Financial increased their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Guggenheim reissued a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a research note on Monday, February 2nd. UBS Group restated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.